Differential expression of eicosanoid pathways after whole blood stimulation in asthma patients
Chrysanthi Skevaki(Harvard University), Thomas Bahmer(Christian-Albrechts-Universität zu Kiel), Pavel Tafo(Universities of Giessen and Marburg Lung Center), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Frauke Pedersen, Christian Herzmann, Henrik Watz(German Center for Lung Research), Mustafa Abdo(Heidelberg University), Wolfgang Andreas Nockher(Goethe University Frankfurt), Harald Renz(Philipps University of Marburg)
Cited by 3
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Factors Associated with Persistent Airflow Limitation in Severe Asthma
|American Journal of Respiratory and Critical Care Medicine|2001|360